Discover
TLX
Telix Pharmaceuticals Limited
11.84
1 x 12.01
1 x 11.98
bid
ask
+
0.00
0.00%
11:23 AM
timesize
| Ytd | 58.08% | |
| 1y | -28.24% |
11.83
day range
12.17
6.28
52 week range
16.98
| Open | 12.09 | Prev Close | 11.84 | Low | 11.83 | High | 12.17 | Mkt Cap | 4.01B |
| Vol | 96.95K | Avg Vol | 187.38K | EPS | -0.02 | P/E | N/A | Forward P/E | 49.58 |
| Beta | 0.59 | Short Ratio | 1.08 | Inst. Own | 0.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 10.22 | 200-d Avg | 9.21 | 1yr Est | 20.51 |
| Income Statement | |||
| Weighted Average Shares | 334.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 141.87M | ||
| Cash and Equivalents (USD) | 95.21M | ||
| Investments | 37.09M | ||
| Investments Non-Current | 37.09M | ||
| Trade and Non-Trade Receivables | 129.20M | ||
| Current Assets | 330.28M | ||
| Property, Plant & Equipment Net | 115.61M | ||
| Total Assets | 1.16B | ||
| Debt Current | 18.66M | ||
| Total Debt | 467.11M | ||
| Current Liabilities | 231.62M | ||
| Debt Non-Current | 448.45M | ||
| Total Liabilities | 748.61M | ||
| Accumulated Retained Earnings (Deficit) | -154.54M | ||
| Shareholders Equity | 415.38M | ||
| Shareholders Equity (USD) | 278.78M | ||
| Assets Non-Current | 833.71M | ||
| Total Debt (USD) | 313.49M | ||
| Deferred Revenue | 402.00K | ||
| Goodwill and Intangible Assets | 592.82M | ||
| Inventory | 37.08M | ||
| Liabilities Non-Current | 516.99M | ||
| Trade and Non-Trade Payables | 150.35M | ||
| Tax Assets | 65.40M | ||
| Tax Liabilities | 75.45M | ||